Health & Environmental Research Online (HERO)


Print Feedback Export to File
8250903 
Journal Article 
Fluotracen (SKF 28, 175): A new antidepressant. Double-blind study with amitriptyline 
Feldmann, HS; Denber, HCB 
1980 
4 
1 
51-55 
English 
In this double-blind study of a new antidepressant Fluotracen vs amitriptyline in 30 patients, the clinical results indicated that: 1. 1. Fluotracen is a rapidly acting antidepressant with clinical effects apparent often in 4 days. 2. 2. The maximum dosage was 200 mg/day. 3. 3. The mean effective dosage was 100 mg/day. 4. 4. The side effects were minimal. 5. 5. This compound warrants further investigation on a much larger sample and will probably represent the forerunner of a second generation of antidepressants where rapidity of onset of action is the desired effect with minimum of toxicity. © 1980. 
amitriptyline; antidepressant; depressive states; double-blind study; fluotracen